Schedule 13G ownership disclosure
CardioGenics Holdings Inc.
Common Stock $0.00001 par value · CUSIP: 14160X203
Event date: 2025-03-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iliad Research & Trading, L.P.
Shares: 2,415,275.00 · Class: 9.9%
- Iliad Management, LLC
Shares: 2,415,275.00 · Class: 9.9%
- Fife Trading, Inc.
Shares: 2,415,275.00 · Class: 9.9%
- John M Fife
Shares: 2,415,275.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001462830-25-000001
- Form type
- SCHEDULE 13G/A
- Filer
- CardioGenics Holdings Inc.
- CIK
- CIK 1089029
- Filed
- Mar 11, 2025
- Reporting period
- Mar 11, 2025
- Description
- Schedule 13G beneficial ownership